Scleroderma's 5-year survival rate is approximately 85 percent, while the 10-year survival rate is below 70 percent; however, this may vary depending on the subtype. The leading cause of death among scleroderma patients is lung disease, but other causes of death include scleroderma renal crisis, pulmonary fibrosis and pulmonary hypertension.About 60 percent of scleroderma-related deaths occur as a result of lung complications, as reported by the New York Times health guide.
Scleroderma patients are also at high risk of contracting cancer.Despite the fact that there is no known cure for it, the prognosis for scleroderma patients can be improved via treatment of complications and close monitoring of general health, particularly high blood pressure. The symptoms for scleroderma depend on the type of scleroderma and the individual affected, and its seriousness depends on the affected body parts. The treatments for scleroderma should be directed towards the specific features affecting the different parts of the body.
An estimated 300,000 Americans suffer from scleroderma, and about 33.3 percent of them have systemic scleroderma, according to the Scleroderma Foundation. While cases of localized scleroderma arehigher in children, the systematic form of scleroderma is more rampant amongadults. The complications associated with scleroderma may greatly impact the well-being of the patient.